New diabetes clinical trial: Fibrosis Lessens After Metabolic Surgery
Published on: April 18, 2024 at 11:00PM Conditions : Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis (MASH); Liver Fibrosis; Obesity Interventions : Procedure: Metabolic surgery; Drug: Incretin-Based Therapy Sponsors : Ali Aminian Not yet recruiting https://ift.tt/FXbHVh6